PRAX
Praxis Precision Medicines, Inc.
NASDAQ · USHealthcareBiotechnology
$304.43-3.17%
Price as of Jul 20, 2026
PRAX valuation
Praxis Precision Medicines, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 32.53x
- P/S forward
- 129.97x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.02x
- Price / sales
- —
- Price / cash flow
- -30.02x
Enterprise value
- Enterprise value
- $7.7B
- EV / sales
- —
- EV / EBITDA
- -23.60x
- EV / EBIT
- -21.55x
- Market cap
- $8.5B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.